Using Proteomics to Stage Alzheimer's Disease

Biofluid proteomics can reveal multiple brain-based pathologies that evolve over the course of AD and holds promise for staging the disease. Additional proteomic studies in longitudinal cohorts are required to better define staging in LOAD.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-12-01
DOI
https://doi.org/10.1002/alz70856_098759
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Using Proteomics to Stage Alzheimer's Disease

Erik C.B. Johnson
Alzheimer s & Dementia
Alzheimer's disease research and treatments
article

Using Proteomics to Stage Alzheimer's Disease

Erik C.B. Johnson
article en

Abstract

Biofluid proteomics can reveal multiple brain-based pathologies that evolve over the course of AD and holds promise for staging the disease. Additional proteomic studies in longitudinal cohorts are required to better define staging in LOAD.

Alzheimer s & DementiaVol. 21(S2)
Emory University (US)
Openalex Percentile: Top 33%
Alzheimer's disease research and treatments
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Using Proteomics to Stage Alzheimer's Disease — Erik C.B. Johnson · Alzheimer s & Dementia (2025) | TGRS Research Map | TGRS